These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8252745)
1. Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension. Sekihara H; Yonemitsu K; Yazaki Y Clin Endocrinol (Oxf); 1993 Nov; 39(5):557-60. PubMed ID: 8252745 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces the release of 19-hydroxyandrostenedione in man. Sekihara H; Torii R; Osawa Y; Takaku F J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318 [TBL] [Abstract][Full Text] [Related]
3. 19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man. Sekihara H J Steroid Biochem; 1983 Jul; 19(1A):353-8. PubMed ID: 6310235 [TBL] [Abstract][Full Text] [Related]
4. 19-hydroxyandrostenedione and 6 beta-hydroxyandrostenedione: new steroids regulated by the renin-angiotensin system in man. Sekihara H J Steroid Biochem; 1984 Jan; 20(1):383-5. PubMed ID: 6708521 [TBL] [Abstract][Full Text] [Related]
5. 6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent. Sekihara H Clin Exp Hypertens A; 1983; 5(1):1-9. PubMed ID: 6339119 [TBL] [Abstract][Full Text] [Related]
6. 19-hydroxyandrostenedione as a new hypertensinogenic agent. Sekihara H J Steroid Biochem; 1982 Feb; 16(2):329-31. PubMed ID: 7043093 [TBL] [Abstract][Full Text] [Related]
7. 19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids. Sekihara H Endocrinology; 1983 Sep; 113(3):1141-8. PubMed ID: 6347666 [TBL] [Abstract][Full Text] [Related]
15. Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups. Rayner BL; Myers JE; Opie LH; Trinder YA; Davidson JS S Afr Med J; 2001 Jul; 91(7):594-9. PubMed ID: 11544978 [TBL] [Abstract][Full Text] [Related]
16. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone. Witzgall H; Thayil G; Weber PC Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560 [TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity. Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of the hypertensinogenic action of 19-hydroxyandrostenedione by aromatase inhibitor, delta 1-testololactone. Sekihara H; Yonemitsu K; Takaku F Endocrinology; 1987 Dec; 121(6):1931-6. PubMed ID: 3678133 [TBL] [Abstract][Full Text] [Related]
19. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension]. Musca A; Ferri C; Cammerella I; Onofri R; Tani S; Santucci A Medicina (Firenze); 1989; 9(2):167-72. PubMed ID: 2530412 [TBL] [Abstract][Full Text] [Related]